264 related articles for article (PubMed ID: 33201250)
1. Intrinsically disordered features of carbonic anhydrase IX proteoglycan-like domain.
Langella E; Buonanno M; De Simone G; Monti SM
Cell Mol Life Sci; 2021 Mar; 78(5):2059-2067. PubMed ID: 33201250
[TBL] [Abstract][Full Text] [Related]
2. Biochemical, biophysical and molecular dynamics studies on the proteoglycan-like domain of carbonic anhydrase IX.
Langella E; Buonanno M; Vullo D; Dathan N; Leone M; Supuran CT; De Simone G; Monti SM
Cell Mol Life Sci; 2018 Sep; 75(17):3283-3296. PubMed ID: 29564477
[TBL] [Abstract][Full Text] [Related]
3. Unique epitope-antibody interactions in the intrinsically disordered proteoglycan-like domain of human carbonic anhydrase IX defined by high-resolution NMR combined with yeast surface display.
Ni F; Wu C; Xu P; Wang P; Fortin Y; Arbour M; Masson L; L'Abbé D; Acel A; Gosselin M; Lenferink AEG
MAbs; 2023; 15(1):2248672. PubMed ID: 37622732
[TBL] [Abstract][Full Text] [Related]
4. The proteoglycan region of the tumor-associated carbonic anhydrase isoform IX acts as anintrinsic buffer optimizing CO2 hydration at acidic pH values characteristic of solid tumors.
Innocenti A; Pastorekova S; Pastorek J; Scozzafava A; De Simone G; Supuran CT
Bioorg Med Chem Lett; 2009 Oct; 19(20):5825-8. PubMed ID: 19751975
[TBL] [Abstract][Full Text] [Related]
5. Anticancer carbonic anhydrase inhibitors: a patent review (2008 - 2013).
Monti SM; Supuran CT; De Simone G
Expert Opin Ther Pat; 2013; 23(6):737-49. PubMed ID: 23672415
[TBL] [Abstract][Full Text] [Related]
6. Crystal structure of the catalytic domain of the tumor-associated human carbonic anhydrase IX.
Alterio V; Hilvo M; Di Fiore A; Supuran CT; Pan P; Parkkila S; Scaloni A; Pastorek J; Pastorekova S; Pedone C; Scozzafava A; Monti SM; De Simone G
Proc Natl Acad Sci U S A; 2009 Sep; 106(38):16233-8. PubMed ID: 19805286
[TBL] [Abstract][Full Text] [Related]
7. Carbonic anhydrase IX: Biochemical and crystallographic characterization of a novel antitumor target.
De Simone G; Supuran CT
Biochim Biophys Acta; 2010 Feb; 1804(2):404-9. PubMed ID: 19679200
[TBL] [Abstract][Full Text] [Related]
8. Targeting tumor-associated carbonic anhydrase IX in cancer therapy.
Thiry A; Dogné JM; Masereel B; Supuran CT
Trends Pharmacol Sci; 2006 Nov; 27(11):566-73. PubMed ID: 16996620
[TBL] [Abstract][Full Text] [Related]
9. Pyridinium derivatives of 3-aminobenzenesulfonamide are nanomolar-potent inhibitors of tumor-expressed carbonic anhydrase isozymes CA IX and CA XII.
Akocak S; Güzel-Akdemir Ö; Kishore Kumar Sanku R; Russom SS; Iorga BI; Supuran CT; Ilies MA
Bioorg Chem; 2020 Oct; 103():104204. PubMed ID: 32891000
[TBL] [Abstract][Full Text] [Related]
10. Sulfocoumarin-, Coumarin-, 4-Sulfamoylphenyl-Bearing Indazole-3-carboxamide Hybrids: Synthesis and Selective Inhibition of Tumor-Associated Carbonic Anhydrase Isozymes IX and XII.
Angapelly S; Sri Ramya PV; Angeli A; Supuran CT; Arifuddin M
ChemMedChem; 2017 Oct; 12(19):1578-1584. PubMed ID: 28940980
[TBL] [Abstract][Full Text] [Related]
11. Carbonic anhydrase inhibitors. Synthesis, and molecular structure of novel series N-substituted N'-(2-arylmethylthio-4-chloro-5-methylbenzenesulfonyl)guanidines and their inhibition of human cytosolic isozymes I and II and the transmembrane tumor-associated isozymes IX and XII.
Żołnowska B; Sławiński J; Pogorzelska A; Chojnacki J; Vullo D; Supuran CT
Eur J Med Chem; 2014 Jan; 71():135-47. PubMed ID: 24291567
[TBL] [Abstract][Full Text] [Related]
12. Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides incorporating thioureido-sulfanilyl scaffolds.
Puccetti L; Fasolis G; Cecchi A; Winum JY; Gamberi A; Montero JL; Scozzafava A; Supuran CT
Bioorg Med Chem Lett; 2005 May; 15(9):2359-64. PubMed ID: 15837325
[TBL] [Abstract][Full Text] [Related]
13. Biophysical Characterization of Cancer-Related Carbonic Anhydrase IX.
Koruza K; Murray AB; Mahon BP; Hopkins JB; Knecht W; McKenna R; Fisher SZ
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32722392
[TBL] [Abstract][Full Text] [Related]
14. Carbonic anhydrase inhibitors. Design of fluorescent sulfonamides as probes of tumor-associated carbonic anhydrase IX that inhibit isozyme IX-mediated acidification of hypoxic tumors.
Cecchi A; Hulikova A; Pastorek J; Pastoreková S; Scozzafava A; Winum JY; Montero JL; Supuran CT
J Med Chem; 2005 Jul; 48(15):4834-41. PubMed ID: 16033263
[TBL] [Abstract][Full Text] [Related]
15. Selective carbonic anhydrase IX inhibitors based on coumarin scaffold as promising antimetastatic agents: WO2012070024.
Carradori S
Expert Opin Ther Pat; 2013; 23(6):751-6. PubMed ID: 23387899
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of the tail hydrophobic interactions within the carbonic anhydrase IX active site via structural extension: Design and synthesis of novel N-substituted isatins-SLC-0111 hybrids as carbonic anhydrase inhibitors and antitumor agents.
Eldehna WM; Abo-Ashour MF; Nocentini A; El-Haggar RS; Bua S; Bonardi A; Al-Rashood ST; Hassan GS; Gratteri P; Abdel-Aziz HA; Supuran CT
Eur J Med Chem; 2019 Jan; 162():147-160. PubMed ID: 30445264
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of novel isoindoline-1,3-dione-based oximes and benzenesulfonamide hydrazones as selective inhibitors of the tumor-associated carbonic anhydrase IX.
Abdel-Aziz AA; El-Azab AS; Abu El-Enin MA; Almehizia AA; Supuran CT; Nocentini A
Bioorg Chem; 2018 Oct; 80():706-713. PubMed ID: 30064081
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of carbonic anhydrase IX targets primary tumors, metastases, and cancer stem cells: Three for the price of one.
Supuran CT; Alterio V; Di Fiore A; D' Ambrosio K; Carta F; Monti SM; De Simone G
Med Res Rev; 2018 Sep; 38(6):1799-1836. PubMed ID: 29635752
[TBL] [Abstract][Full Text] [Related]
19. A comparative study of the binding modes of SLC-0111 and its analogues in the hCA II and hCA IX active sites using QM/MM, molecular docking, MM-GBSA and MD approaches.
Chahal V; Nirwan S; Kakkar R
Biophys Chem; 2020 Oct; 265():106439. PubMed ID: 32738591
[TBL] [Abstract][Full Text] [Related]
20. Carbonic anhydrase IX as a target for designing novel anticancer drugs.
Monti SM; Supuran CT; De Simone G
Curr Med Chem; 2012; 19(6):821-30. PubMed ID: 22214452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
